BIB vs. BIDG

Last updated Jun 23, 2026

BIB (ProShares Ultra Nasdaq Biotechnology) and BIDG (Leverage Shares 2X Long BIDU Daily ETF) are both Leveraged Equities funds - BIB tracks the NASDAQ Biotechnology Index (200%) while BIDG tracks the Baidu, Inc. (BIDU). Both are passively managed. At a 0.32 correlation, their price movements are largely independent. BIB charges 0.95%/yr vs 0.75%/yr for BIDG.

Performance

BIB vs. BIDG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Nasdaq Biotechnology (BIB) and Leverage Shares 2X Long BIDU Daily ETF (BIDG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BIB achieves a 10.33% return, which is significantly higher than BIDG's -38.40% return.

BIB

• 1D: 3.51%
• 1M: 7.37%
• YTD: 10.33%
• 6M: 5.76%
• 1Y: 95.42%
• 3Y*: 18.87%
• 5Y*: -0.66%
• 10Y*: 9.50%

BIDG

• 1D: 0.32%
• 1M: -25.33%
• YTD: -38.40%
• 6M: -31.83%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BIB vs. BIDG - Yearly Performance Comparison

	2026 (YTD)	2025
BIB ProShares Ultra Nasdaq Biotechnology	10.33%	1.96%
BIDG Leverage Shares 2X Long BIDU Daily ETF	-38.40%	17.04%

Correlation

The correlation between BIB and BIDG is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Dec 18, 2025	0.32

Return for Risk

BIB vs. BIDG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIB

BIB Risk / Return Rank: 76
BIB Sharpe Ratio Rank: 77
BIB Sortino Ratio Rank: 67
BIB Omega Ratio Rank: 58
BIB Calmar Ratio Rank: 91
BIB Martin Ratio Rank: 85

BIDG

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BIB vs. BIDG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and Leverage Shares 2X Long BIDU Daily ETF (BIDG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BIB	BIDG	Difference
Sharpe ratio: Return per unit of total volatility	2.38	—	—
Sortino ratio: Return per unit of downside risk	2.97	—	—
Omega ratio: Gain probability vs. loss probability	1.35	—	—
Calmar ratio: Return relative to maximum drawdown	5.67	—	—
Martin ratio: Return relative to average drawdown	17.31	—	—

Drawdowns

BIB vs. BIDG - Drawdown Comparison

The maximum BIB drawdown since its inception was -67.24%, which is greater than BIDG's maximum drawdown of -59.34%. Use the drawdown chart below to compare losses from any high point for BIB and BIDG.

Drawdown Indicators

	BIB	BIDG	Difference
Max Drawdown Largest peak-to-trough decline	-67.24%	-59.34%	-7.90%
Max Drawdown (1Y) Largest decline over 1 year	-16.92%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-45.30%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-65.86%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-66.20%	—	—
Current Drawdown Current decline from peak	-18.88%	-59.01%	+40.13%
Average Drawdown Average peak-to-trough decline	-32.71%	-33.92%	+1.21%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.53%	—	—

Volatility

Volatility by Period

	BIB	BIDG	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.51%	—	—
Volatility (6M) Calculated over the trailing 6-month period	31.64%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	40.47%	103.20%	-62.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.60%	103.20%	-59.60%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	46.50%	103.20%	-56.70%

BIB vs. BIDG - Expense Ratio Comparison

BIB has a 0.95% expense ratio, which is higher than BIDG's 0.75% expense ratio.

Dividends

BIB vs. BIDG - Dividend Comparison

BIB's dividend yield for the trailing twelve months is around 0.56%, while BIDG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022
BIB ProShares Ultra Nasdaq Biotechnology	0.56%	0.77%	1.69%	0.07%	0.03%
BIDG Leverage Shares 2X Long BIDU Daily ETF	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BIB and BIDG in my portfolio?

BIB and BIDG have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, BIB or BIDG?

On fees, BIDG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, BIB or BIDG?

BIDG is cheaper with a 0.75% expense ratio, compared with 0.95% for BIB.

Which ETF pays a higher dividend yield, BIB or BIDG?

BIB has the higher dividend yield at 0.56%, compared with 0.00% for BIDG.

What is the main difference between BIB and BIDG?

BIB tracks NASDAQ Biotechnology Index (200%), while BIDG tracks Baidu, Inc. (BIDU). They also come from different issuers: ProShares and Leverage Shares. Their fees differ too: 0.95% for BIB and 0.75% for BIDG.